Laseroptek develops the novel PALLAS Solid-State 311nm UVB laser for the treatment of diseases such as atopic dermatitis, psoriasis, vitiligo and leukoderma.
The novel laser designed with the latest technology provides an effective treatment option for billions of people worldwide affected with skin diseases.
The latest technology of the laser uses 308 or 311 nanometer versions by providing physicians flexibility and at the same time excluding the need for costly and time-consuming excimer gas and electrode replacements.
PALLAS Solid-State UVB laser is clinically proven and will provide safe and effective treatment options for difficult-to-treat skin conditions like vitiligo, psoriasis, atopic dermatitis and leukodermas. Moreover, this laser will provide a much-needed option to physicians and deliver great results for patients.
FDA clears PALLAS Solid-State UVB Medical Dermatology Laser for the safe and effective treatment of Vitiligo, Psoriasis, Atopic Dermatitis and Leukodermas.